SO

Stuart Thomas Onions

RE Respivert: 7 patents #2 of 32Top 7%
TL Topivert Pharma Limited: 2 patents #4 of 21Top 20%
PL Pulmocide Limited: 1 patents #1 of 8Top 15%
📍 Bilsthorpe, GB: #1 of 3 inventorsTop 35%
Overall (2017): #10,501 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9850231 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, John King-Underwood, Alistair Ian Longshaw, Rudy Laurent Maria Broeckx +2 more 2017-12-26
9771354 Pyrazole p38 map kinase inhibitors John King-Underwood, George Hardy, Peter John Murray, Jonathan Gareth Williams 2017-09-26
9745306 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors Rudy Laurent Maria Broeckx, Alex Herman Copmans, Alun John Smith, David Michel Adrien Taddei 2017-08-29
9732098 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative Simon Fraser Hunt, Vladimir Sherbukhin, Euan Alexander Fraser Fordyce, Peter John Murray, Daniel William Brookes +2 more 2017-08-15
9724347 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, John King-Underwood, Alistair Ian Longshaw 2017-08-08
9701670 Pyrazolyl-ureas as kinase inhibitors Claire Anne Marie Cariou, Catherine Elisabeth Charron, Euan Alexander Fraser Fordyce, Daniel Hamza, Matthew Colin Thor Fyfe +6 more 2017-07-11
9624196 Inhibitor of p38 MAP kinase Alistair Ian Longshaw, Euan Alexander Fraser Fordyce, John King-Underwood, Jennifer D. Venable 2017-04-18
9556184 Phosphoinositide 3-kinase inhibitors David Michel Adrien Taddei, Alun John Smith, Alex Herman Copmans, Rudy Laurent Maria Broeckx 2017-01-31